Our commitment to cutting edge infrastructure is designed to support biorepository sciences and immortalize samples as renewable assets
The structure includes manufacturing facilities for kit collections, sophisticated and integrated sample accessioning spaces for primary clinical samples and state of the art laboratories equipped with semi and fully automated instrumentation. We have Sampled sites in New Jersey, USA, Minnesota, USA and Glasgow, UK. We also have partner sites in Australia, China and The Netherlands.
This infrastructure provides the flexibility needed to offer a multitude of services for projects that vary in sample volume and size while maintaining effective and efficient processing times and costs.
Continuous investment in analytical facilities
1 petabyte and counting of data stored
Laboratory Processing Facilities
Over 11 million COVID samples processed
Ambient to -190°C storage facilities